Balloon Catheters Market, by Product Type (Over-the-wire (OTW) Balloon Catheters, Rapid Exchange (RX) Balloon Catheters, and Fixed-wire (FW) Balloon Catheters),by Balloon Type (Noncompliant (High-pressure) Balloons, Semi-compliant (Midpressure) Balloons, and Compliant (Elastomeric) Balloons), by Material (Polyurethane, Nylon, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Published In : Nov 2019

Code : CMI489

Pages :168

Formats :

Excel and PDF

Industry : Medical Devices

Regional Analysis

Global Balloon Catheters Market- Regional Analysis

Regional segmentation of the global balloon catheters market includes North America, Latin America, Europe, Asia Pacific, Middle East, and Africa

Among regions, North America is expected to account for the largest share in the global balloon catheters market, owing to increasing regulatory approvals and product launches in the region. For instance, In June 2017, OrbusNeich, a medical device company, launched its Sapphire percutaneous coronary angiography balloon dilatation catheters (Sapphire II PRO and Sapphire NC Plus) after receiving 510k clearance by the U.S. FDA.

Furthermore, Asia Pacific balloon catheters market is expected to witness significant growth over the forecast period, owing to presence of major key players in the region such as Terumo Corporation, Kaneka Corporation, and BrosMed Medical. These players are focusing on the product development and launching of innovative balloon catheters. For instance, in November 2017, Kaneka Corporation, a company based in Minato, Tokyo, launched a high-pressure balloon catheter, SHIDEN HP. The novel SHIDEN HP is used for enlarging a blood vessel at high pressure for calcified lesions due to progressed peripheral arterial disease (PAD). Moreover, in August 2017, BrosMed Medical received Japan Pharmaceuticals and Medical Devices Agency (PMDA) approval for its Artimes and Apollo Percutaneous transluminal coronary angioplasty (PTCA) balloons. Artimes is a semi-compliant pre-dilatation PTCA balloon, and Apollo is a non-complaint high pressure post-dilatation PTCA balloon.

Europe is also expected to show significant growth in balloon catheters market over the forecast period, owing to increasing prevalence of cardiovascular diseases (CVD) in the region. For instance, according to the European Heart Network AISBL, in 2015, there were around 11.3 million new cases of CVD diagnosed in Europe and 6.1 million new cases of CVD diagnosed in the European Union. Such increasing prevalence is expected to drive demand of the balloon catheters in the region.